INNOPEG LIMITED
Significant control: Silence Therapeutics PLC (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Innopeg Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Innopeg Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
INNOPEG LIMITED is an active private limited company (company number 03555265) incorporated on 29 April 1998, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 31 December 2024, showing net assets of £120k. Net assets were unchanged on the prior period.
By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).
Ownership and control
- Silence Therapeutics Plc
- owns 75–100% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 29 April 199828 yrs ago
- Next accounts due
- 30 September 202625 days overdue
- Confirmation statement due
- 13 May 2027in 200 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | £120k | — | — | — | — | — | — |
| 31 December 2023 | £120k | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £120,000 at 31 December 2024
- Incorporated five or more years agoIncorporated 29 April 1998
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 200 days
- Next accounts due25 days overdue
- Accounts period endNet assets £120k · dormant accounts
- Accounts period endNet assets £120k · dormant accounts
- Incorporated
Similar companies in London
- CANCER RESEARCH VENTURES LIMITEDLondon · inc. Feb 1998
- TIZIANA LIFE SCIENCES LIMITEDLondon · inc. Feb 1998
- COGENT (HOLDINGS) LIMITEDLondon · inc. Nov 1998
- LIPOXEN TECHNOLOGIES LIMITEDLondon · inc. Jul 1997
- MEDEZRIN LTD.London · inc. Mar 1997
- NUCANA PLCLondon · inc. Jan 1997
All companies incorporated on 29 April 1998 · in Apr 1998.
Reminders for INNOPEG LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.